Published • loading... • Updated
TFG-001 Shows Enhanced Reinnervation and Functionality in Parkinson’s Disease
Summary by World Business Outlook
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
TFG-001 Shows Enhanced Reinnervation and Functionality in Parkinson’s Disease
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, on May 25th announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-i…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
